Valerie Daggett is the founder of AltPep. AltPep has raised $76M in total funding. Latest round: Series B. Based in Seattle, United States.
Dr. Valerie Daggett is the Founder and CEO of AltPep Corporation, a Seattle-based biotech company focused on diagnostic and therapeutic solutions for amyloid diseases like Alzheimer's. She has led AltPep to secure FDA Breakthrough Device designation for its assay and has raised over $76 million.
Full founder directory · Investor directory · Company funding database · Fundraising library